Background/Aim: The prognostic and predictive value of Kirsten rat sarcoma viral oncogene
homolog (KRAS) mutation in non-small cell lung cancer (NSCLC) is not well established …

Background: Mitochondria have emerged as a major target for anticancer therapy because
of their critical role in cancer cell survival. Our preliminary works have suggested that …

Background: Hyponatremia is a well-known phenomenon in cancer patients. The aim of our
retrospective study was to assess the relationship of natremia levels to predict treatment with …

The majority of patients with lung cancer present with advanced stage which contributes to
death of more people than any other malignancy in the world. The discovery of a number of …

The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …

目的观察同步放化疗治疗老年局限期小细胞肺癌(limited-stage small cell lung cancer, LSCLC)
的效果. 方法选取2008 年1 月—2013 年1 月解放军白求恩国际和平医院肿瘤科收治的符合纳入 …

Background: The usefulness of serum proteomic test (VeriStrat) in African-Americans with
non-small cell lung cancer (NSCLC) as well as the relationship between comorbidity and …

目的探讨不同化疗剂量强度对肺癌患者近期疗效以及不良反应的影响. 方法临床纳入Ⅲb~ Ⅳ
期非小细胞肺癌患者396 例, 所有患者均采用多西他赛单药方案二线化疗 …

To determine the efficacy and toxicity of Pemetrexed plus Oxaliplatin in patients suffering
from stage IIIb or IV lung adenocarcinoma and being treated with Erlotinib as second-line …

Background: This systemic analysis was conducted to evaluate the efficacy and safety of
pemetrexed based chemotherapy in treating patients with metastatic gastric cancer (MGC) …